Clinical Study Results
In this study, the researchers found there were 13.3% of participants who had
DLTs. This was 8 out of 60 participants:
• 33.3% of participants in Group 2 had at least 1 DLT. This was 2 out of
6 participants.
• 22.2% of participants in Group 7 had at least 1 DLT. This was 2 out of
9 participants.
• 12.5% of participants in Group 9 had at least 1 DLT. This was 2 out of
16 participants.
• 100.0% of participants in Group 10 had at least 1 DLT. This was 2 out of
2 participants.
• None of the participants in Groups 1, 3, 4, 5, 6, or 8 had DLTs
The figure below shows these results.
DLTs during the study
Group 2 Group 7
33.3% had a DLT 22.2% had a DLT
(2 out of 6 (2 out of 9
participants) participants)
Group 9 Group 10
12.5% had a DLT 100% had a DLT
(2 out of 16 (2 out of 2
participants) participants)
What medical problems did the participants
have during the study?
This section is a summary of the medical problems the participants had during
the study that the study doctors thought might be related to the study drug.
These medical problems are called “adverse reactions”. An adverse reaction
is considered “serious” when it is life-threatening, causes lasting problems, or
requires hospital care.
5